Drug intelligence / Profile preview

pennogenin 3-O-beta-chacotrioside

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Pennogenin 3-O-beta-chacotrioside, also known as Polyphyllin VII, is a steroidal saponin isolated from the rhizomes of Paris polyphylla, a plant widely used in traditional Chinese medicine for its anti-cancer properties. It has been identified as a primary bioactive constituent in the ethanolic extract of P. polyphylla (EEPP) and is being investigated for its efficacy against colorectal cancer. The compound induces cell death in human colorectal carcinoma cells, such as the DLD-1 line, by upregulating autophagy markers. This mechanism of action is notably independent of p53 and caspase-3 activation, suggesting a non-apoptotic pathway for tumor suppression. Furthermore, pennogenin 3-O-beta-chacotrioside has demonstrated synergistic potential when used in combination with the chemotherapeutic drug doxorubicin, significantly enhancing cytotoxicity in tumor cells.

Other names
Polyphyllin VIIpennogenin 3-O-chacotriosidepennogenin3-O-chacotriosidepennogenin-3-O-chacotriosidepennogenin 3-O-alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside
02

Targets

Beyond the preview

Go deeper on pennogenin 3-O-beta-chacotrioside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pennogenin 3-O-beta-chacotrioside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call